EIR Brochure Final 2 Paperturn - Flipbook - Page 11
SIMON HOLLINGSWORTH
VP, Global Medicine Leader
Astrazeneca
Simon is Vice President and Global
Medicine Leader at AstraZeneca
accountable for the global life-cycle
development and commercialisation
of Lynparza. He has >20 years’
experience in drug/therapeutics
development across industry and
academic careers focused in clinical
drug development, clinical and
translational science, and precision
medicine (oncology, inflammation,
cardio-/vascular).
Simon can advise on:
Clinical drug development.
Clinical and translational science.
Precision medicine.
Industry / Academia partnerships
– collaborating and working in
Alliances.
Drug discovery.
Career development.
RACHEL HEMSLEY
COLIN T DOURISH
ANTHONY BROWN
Business Development Director
Sygnature Discovery
Director & Co-Owner
P1vital and P1vital products
Rachel is responsible for setting
and delivering the business
strategy of Sygnature Discovery.
Rachel was previously the Senior
Business Manager at UCL Business
plc and has 12 years’ experience
in business development involving
early stage technology
development, securing investment
funding, licensing early stage
healthcare technology and setting
up new companies.
Colin has a successful track
record in CNS drug discovery and
drug development in both major
pharmaceutical and biotechnology
companies. Prior to co-founding
P1vital and P1vital Products, he
was Senior Vice President
Research and CSO of Vernalis
Group plc, Research Director and
co-founder of Cerebrus Limited,
Director of Neuropharmacology
at Wyeth Research and Section
Head at Merck.
Over 30 years of experience leading
small molecule & biological drug
discovery programmes. Primary
focus in oncology, immuneoncology, inflammation and fibrosis
- covering target identification &
validation, R&D, clinical studies
(Ph1/2/3), manufacturing and
companion diagnostics. Direct
experience leading M&A, inlicensing, financing through IPOs,
private investments and grants.
Colin can advise on:
Drug discovery in CNS
disorders, eating disorders
and obesity.
Drug discovery and
translational projects.
Clinical development
strategy.
Career development.
Anthony can advise on:
Drug discovery of small
molecules, biologicals and cellbased therapies.
Routes to progress drug
discovery and translational
projects.
Career development.
Rachel can advise on:
Stem cell therapies.
Diagnostics.
Medical devices.
Routes to develop
translational research
projects.
VP Business Development & Scientific Liaison
Carrick Therapeutics